Drug Prices Negotiated by Medicare Still Higher Than Other Countries’

MedPage Today December 2, 2024
Shannon Firth

— All drugs except one remained more expensive in the U.S.

Prices for the first 10 drugs negotiated by Medicare fell from their initial net prices, but all drugs except one remained more expensive in the U.S. than in peer countries, researchers said.

Compared with their net prices prior to negotiation, negotiated prices for the 10 drugs ranged from 8% lower for dapagliflozin (Farxiga) to 42% lower for sitagliptin (Januvia), reported Olivier J. Wouters, PhD, of the London School of Economics and Political Science, and co-authors.

Specifically, the price of dapagliflozin dropped from $193.80 to $178.50 per 30-day supply, while the price of 30 days of sitagliptin fell from $195.60 to $113.00, they noted in a research letter published in...

Today's Sponsors

Today's Sponsor